Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-121364)

Filing Details

Accession Number:: 0001209191-16-121364
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-18 17:23:25
Reporting Period:: 2016-05-17

Filing Date:: 2016-05-18
Accepted Time:: 2016-05-18 17:23:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1419600	Flexion Therapeutics Inc	FLXN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1129890	W Frederick Driscoll	C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-17	2,500	$9.87	8,434	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The weighted average purchase price for the transaction reported was $9.86720, and the range of prices were between $9.72 and $10.029. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.